Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The enhancement of central serotonin system function underlies the therapeutic effects of selective serotonin reuptake inhibitors (SSRIs), which have become the most commonly used class of antidepressant agents. However, many individuals experience depressive episodes that are resistant to SSRI treatment. Homeostatic mechanisms that limit the extent to which SSRIs enhance serotonergic neurotransmission have been implicated in this phenomenon. Here, we report a novel strategy for enhancing the efficacy of SSRIs. Using in vivo microdialysis methods in rats, the nonselective 5-HT2 receptor antagonist ketanserin was observed to produce a robust augmentation of citalopram-, fluoxetine-, and sertraline-induced elevations of hippocampal extracellular serotonin levels. Similar effects were also observed in cortex. The potentiation of SSRI-induced increases in hippocampal serotonin levels was reproduced by the 5-HT(2C) receptor-selective antagonists SB 242084 and RS 102221, but not by the 5-HT(2A) receptor-selective antagonist MDL 100 907. Although 5-HT(2C) receptor antagonists augmented the actions of SSRIs, they had no effect on extracellular serotonin levels or tail suspension responses when administered alone. These results were in strong accord with independent findings using a line of 5-HT(2C) receptor-null mutant mice. Although this mutation did not affect baseline extracellular serotonin levels or tail suspension test (TST) behavior, it enhanced fluoxetine effects on serotonin…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, studies have shown that antagonism of 5-HT 2A/2C receptors can enhance the effects of SSRIs such as fluoxetine. 360 , 361”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [360]
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,416
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors
Tecott, L. H., Sun, L. M., Akana, S. F., Strack, A. M., Lowenstein, D. H., Dallman, M. F., & Julius, D. (1995) · Nature · doi:10.1038/374542a0 · Cited by 1,274
Self-citationDepression: Perspectives from Affective Neuroscience
Davidson, R. J., Pizzagalli, D., Nitschke, J. B., & Putnam, K. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135148 · Cited by 1,138
Artigas, F., Romero, L., de Montigny, C., & Blier, P. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10037-0 · Cited by 655
Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain
Wright, D. E., Seroogy, K. B., Lundgren, K. H., Davis, B. M., & Jennes, L. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903510304 · Cited by 549
Gurevich, I., Tamir, H., Arango, V., Dwork, A. J., Mann, J. J., & Schmauss, C. (2002) · Neuron · doi:10.1016/s0896-6273(02)00660-8 · Cited by 377
Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS
Clemett, D. A., Punhani, T., S. Duxon, M., Blackburn, T. P., & Fone, K. C. F. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00086-6 · Cited by 373
The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?
Roth, B. L., Lopez, E., Patel, S., & Kroeze, W. K. (2000) · The Neuroscientist · doi:10.1177/107385840000600408 · Cited by 358
Martı́n-Ruiz, R., Puig, M. V., Celada, P., Shapiro, D. A., Roth, B. L., Mengod, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09856.2001 · Cited by 339
Gobert, A., Rivet, J.-M., Lejeune, F., Newman-Tancredi, A., Adhumeau-Auclair, A., Nicolas, J.-P., Cistarelli, L., Melon, C., & Millan, M. J. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000601)36:3<205::aid-syn5>3.0.co;2-d · Cited by 336
Role and Origin of the GABAergic Innervation of Dorsal Raphe Serotonergic Neurons
Gervasoni, D., Peyron, C., Rampon, C., Barbagli, B., Chouvet, G., Urbain, N., Fort, P., & Luppi, P.-H. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04217.2000 · Cited by 297
Antidepressant-Like Behavioral Effects Mediated by 5-Hydroxytryptamine2C Receptors
Cryan, J. F., & Lucki, I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39013-5 · Cited by 293
Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice
Vickers, S. P., Clifton, P. G., Dourish, C. T., & Tecott, L. H. (1999) · Psychopharmacology · doi:10.1007/s002130050952 · Cited by 291
Self-citationAnimal Models of Depression: Utility for Transgenic Research
Porsolt, R. D. (2000) · Reviews in the Neurosciences · doi:10.1515/revneuro.2000.11.1.53 · Cited by 285
Kreiss, D. S., & Lucki, I. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10650-2 · Cited by 277
Niswender, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00223-2 · Cited by 256
Bagdy, G., Graf, M., Anheuer, Z. E., Modos, E. A., & Kantor, S. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002632 · Cited by 247
5-HT and antidepressants: new views from microdialysis studies
Artigas, F. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90125-4 · Cited by 215
Liu, R., Jolas, T., & Aghajanian, G. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02468-9 · Cited by 197
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor
Pälvimäki, E. P., Majasuo, H., Laakso, A., Kuoppamäki, M., Syvälahti, E., Roth, B. L., & Hietala, J. (1996) · Psychopharmacology · doi:10.1007/bf02246453 · Cited by 197
Separate systems for serotonin and leptin in appetite control
Halford, J. C. G., & Blundell, J. E. (2000) · Annals of Medicine · doi:10.3109/07853890008998829 · Cited by 180
How does pindolol improve antidepressant action?
Artigas, F., Celada, P., Laruelle, M., & Adell, A. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01682-5 · Cited by 174
Gobert, A., & Millan, M. J. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00188-9 · Cited by 171
Redrobe, J. P., & Bourin, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00115-5 · Cited by 161
Modulation of Serotonin 2C Receptor Editing by Sustained Changes in Serotonergic Neurotransmission
Gurevich, I., Englander, M. T., Adlersberg, M., Siegal, N. B., & Schmauss, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10529.2002 · Cited by 159
5-HT2 Receptor Regulation of Extracellular GABA Levels in the Prefrontal Cortex
Abi-Saab, W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00046-3 · Cited by 158
Leysen, J. E., Janssen, P. M., Gommeren, W., Wynants, J., Pauwels, P. J., & Janssen, P. A. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08945-x · Cited by 150
5-Hydroxytryptamine2 Receptor Facilitates GABAergic Neurotransmission in Rat Hippocampus
Shen, R.-Y., & Andrade, R. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37472-5 · Cited by 135
Neurobiology of Serotonin in Depression and Suicidea
STOCKMEIER, C. A. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52362.x · Cited by 130
Hervás, I. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00175-5 · Cited by 115
New approaches to the treatment of refractory depression.
Fava, M. (2000) · PubMed · Cited by 114
Bankson, M. G., & Cunningham, K. A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00345-1 · Cited by 111
Boothman, L. J., Allers, K. A., Rasmussen, K., & Sharp, T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705328 · Cited by 89
Tao, R., & Auerbach, S. B. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03851-9 · Cited by 78
Mood disorders in the general population represent an important and worldwide public health problem
Judd, L. L. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199512004-00002 · Cited by 70
Brain 5-HT1C receptors and antidepressants
Jenck, F., Moreau, J.-L., Mutel, V., & Martin, J. R. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90013-2 · Cited by 62
Eastwood, S. L., Burnet, P. W. J., & Harrison, P. J. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000601)36:3<167::aid-syn2>3.0.co;2-d · Cited by 48
Cremers, T. I. F. H., Wiersma, L. J., Bosker, F. J., den Boer, J. A., Westerink, B. H. C., & Wikström, H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01093-3 · Cited by 33
Self-citation[Interest of the use of pindolol in the treatment of depression: review].
Brousse, G., Schmitt, A., Chéreau, I., Eschalier, A., Dubray, C., & Llorca, P. (2003) · PubMed · Cited by 11
Cited by
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“360,361 Third, long-term use of SSRIs can increase 5-HT transmission in the LC, 362 thereby increasing the release of GABA to exert inhibitory effects on NA neurons.”
BackgroundBang-Andersen, B., Ruhland, T., Jørgensen, M., Smith, G., Frederiksen, K., Jensen, K. G., Zhong, H., Nielsen, S. M., Hogg, S., Mørk, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101459g · Cited by 606
Self-citationMillan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Serotonin receptors involved in antidepressant effects
Artigas, F. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.006 · Cited by 311
Metadata
- Authors
- Cremers, T. I. F. H., Giorgetti, M., Bosker, F. J., Hogg, S., Arnt, J., Mørk, A., Honig, G., Bøgesø, K.-P., Westerink, B. H. C., den Boer, H., Wikstrom, H. V., & Tecott, L. H.
- Affiliations
- University of Groningen (NL)
- University of California, San Francisco (US)
- University Medical Center Groningen (NL)
- Lundbeck (Denmark) (DK)
- Corresponding author
- Cremers, Thomas I F H
- Tecott, Laurence H
- ORCID
- Honig, Gerard
- Venue
- Neuropsychopharmacology
- Published
- 2004-05-12
- Volume
- 29
- Issue
- 10
- Pages
- 1782-1789
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2124373758
- Cited by
- 157
- References
- 41
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 10 · 2020: 6 · 2019: 1 · 2018: 6 · 2017: 5 · 2016: 7 · 2015: 9 · 2014: 5 · 2013: 8 · 2012: 5
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- 5-HT2C receptor, serotonin reuptake inhibitors, ketanserin, SB242084, fluoxetine, citalopram, sertraline, depression, antidepressant resistance, tail suspension test, immobility
- MeSH terms
- Animals, Brain Chemistry, Ketanserin, Male, Synaptic Transmission, Serotonin, Serotonin Antagonists, Rats, Wistar, Selective Serotonin Reuptake Inhibitors, Microdialysis, Hindlimb Suspension, Receptor, Serotonin, 5-HT2C, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.